Jenni Ilomaki

Jenni Ilomaki

Monash University

H-index: 31

Oceania-Australia

About Jenni Ilomaki

Jenni Ilomaki, With an exceptional h-index of 31 and a recent h-index of 27 (since 2020), a distinguished researcher at Monash University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Future burden of ischemic stroke in Australia: impact on health outcomes between 2019 and 2038

The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 …

Current and Future Cost Burden of Ischemic Stroke in Australia: Dynamic Model

Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia

No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia

The Impact of Frailty on Initiation, Continuation and Discontinuation of Secondary Prevention Medications Following Myocardial Infarction

The effect of frailty on post-discharge management and outcomes of acute glycaemic crises: Analysis of admissions for hypoglycaemia and hyperglycaemia in Australia

SGLT‐2 Inhibitor Use and Cause‐Specific Hospitalization Rates: An Outcome‐Wide Study to Identify Novel Associations of SGLT‐2 Inhibitors

Jenni Ilomaki Information

University

Position

___

Citations(all)

3595

Citations(since 2020)

3045

Cited By

1681

hIndex(all)

31

hIndex(since 2020)

27

i10Index(all)

79

i10Index(since 2020)

65

Email

University Profile Page

Google Scholar

Top articles of Jenni Ilomaki

Future burden of ischemic stroke in Australia: impact on health outcomes between 2019 and 2038

Neuroepidemiology

2024/4/10

The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 …

Journal of Diabetes

2024/4

Stephen Wood
Stephen Wood

H-Index: 39

Jenni Ilomaki
Jenni Ilomaki

H-Index: 20

Current and Future Cost Burden of Ischemic Stroke in Australia: Dynamic Model

Neuroepidemiology

2024/4/1

Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia

European Journal of Preventive Cardiology

2024/3

No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia

International Journal of Cardiology

2024/3/1

The Impact of Frailty on Initiation, Continuation and Discontinuation of Secondary Prevention Medications Following Myocardial Infarction

Archives of Gerontology and Geriatrics

2024/2/13

The effect of frailty on post-discharge management and outcomes of acute glycaemic crises: Analysis of admissions for hypoglycaemia and hyperglycaemia in Australia

Diabetes Research and Clinical Practice

2024/2/9

SGLT‐2 Inhibitor Use and Cause‐Specific Hospitalization Rates: An Outcome‐Wide Study to Identify Novel Associations of SGLT‐2 Inhibitors

Clinical Pharmacology & Therapeutics

2024/2/9

Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study

Osteoporosis International

2024/1/10

Clara Marquina
Clara Marquina

H-Index: 4

Jenni Ilomaki
Jenni Ilomaki

H-Index: 20

Trajectories of prescription opioid tapering in patients with chronic non-cancer pain: a retrospective cohort study, 2015–2020

Pain Medicine

2024/1/8

COX2 inhibitor use and type 2 diabetes treatment intensification: A registry-based cohort study

Diabetes Research and Clinical Practice

2024/1/1

Impact of oral bisphosphonate drug holiday on mortality following hip fracture: a population-based cohort study

The Journal of Clinical Endocrinology & Metabolism

2024/4/17

Clara Marquina
Clara Marquina

H-Index: 4

Jenni Ilomaki
Jenni Ilomaki

H-Index: 20

Global epidemiology of hip fractures: secular trends in incidence rate, post‐fracture treatment, and all‐cause mortality

Journal of Bone and Mineral Research

2023/8/1

Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID‐19 pandemic, 2013–2021: a retrospective cohort study

Medical Journal of Australia

2023/7/3

Acute Kidney Injury, Renal Impairment and Renal Failure Associated with Sodium Glucose Co-transporter-2 Inhibitors in At-Risk Groups: A Systematic Review

2023/5/3

Cohort profile: Using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia.

BMJ open

2023/5/1

Hip fracture incidence and post-fracture mortality in Victoria, Australia: a state-wide cohort study

Archives of Osteoporosis

2023/4/29

Clara Marquina
Clara Marquina

H-Index: 4

Jenni Ilomaki
Jenni Ilomaki

H-Index: 20

Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians …

The Lancet Regional Health–Western Pacific

2023/4/1

Did Australia's COVID-19 restrictions impact statin incidence, prevalence or adherence?

2023/4/1

Trends in survival following dementia diagnosis: a multinational cohort study

2023/3/24

See List of Professors in Jenni Ilomaki University(Monash University)